Life Cycle Investment Partners Ltd

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 2072459 LONDON, X0

Position in VRTX

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$196,660,234

+$30,343,305 QoQ

Shares Held

440,409

+20.1% QoQ

Ownership

0.174%

of shares outstanding

% of Portfolio

1.26%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Life Cycle Investment Partners Ltd holds $298,390,850 across 3 Biotechnology names. VRTX ranks #1 (65.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	440,409	$196,660,234
2	ALNY	Alnylam Pharmaceuticals, Inc.	177,541	$58,742,990
3	ARGX	Argenx SE	58,867	$42,987,626

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$196,660,234	440,409	+20.1%	Shares	Sole	2026-05-12
2025-12-31	$166,316,929	366,854	—	Shares	Sole	2026-02-09
No filing history on record for this holder in this stock.